Archive for 2013

Dr. Vasily, Lehigh Valley Area Dermatologist, Now Offering Solta…

Dr. David Vasily now uses the Fraxel® 1927 Thulium fractional laser, Clear + Brilliant® 1440 and the Clear + Brilliant® Permea devices at his Bethlehem, PA medical office to treat…

(PRWeb March 11, 2013)

Read the full story at

Achieving Optimal Performance from Single-Use Platforms, New Life…

Xtalks presents an exciting live webinar on Wednesday March 27, 2013 at 11:00am EDT on maximizing the investment in a cell culture manufacturing facility. The event features speakers from Fujifilm…(PRWeb March 11, 2013)Read the full story at http…

Bed Bugs Attack New York and Texas Housings; My Cleaning Products…

Reports from and shared that a housing authority in New York and a shelter in Texas were having big problems because of bed bugs. My Cleaning Products, in response to that,…(PRWeb March 11, 2013)Read the full story at http:/…

Non-Toxic Rust Remover Offers Contractors A Quick Way To Cut Labor…

My Cleaning Products highly recommended to rust contractors its rust remover of organic-based ingredients. The company related that the product could cut rust removal labor and even cost by half.(PRWeb March 11, 2013)Read the full story at http://ww…

DNA-o-gram generator — Send a message in the language of life

I programmed the DNA-o-gram generator over a decade ago as an excuse to learn web programming. In the intervening years it has been suggested as an encryption method, used as a teaching aid, and even cited in a law review. The basis for the DNA-o-gram generator is quite simple. The genetic code found in all […]

Biotech in Countries Starting with “I” — Part 3: Italy

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. While the world watches Rome and awaits the upcoming Papal Conclave, the Italian biotechnology sector has been engaged in some soul-searching of its own. With nearly 250 pure biotech […]

Drug Patent Expirations for Feb 25 2013

If your reader cannot render the information below, go to to see the latest expirations


This newsletter is
a free service of DrugPatentWatch

DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents

Drug Patent Expirations for February 25 2013

Tradename Applicant Generic Name Patent
DATSCAN Ge Hlthcare Inc ioflupane i-123 Feb 25, 2013
PREZISTA Janssen Prods darunavir ethanolate Feb 25, 2013

*Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details.


Which pharma companies have the most drug patents

Which Companies Have the Most Active Drug

infographics &raquo

DrugPatentWatch Serves Your Competitive Intelligence

Subscribers have
access to valuable datasets, including:
  • Patent litigation
  • Clinical trial information
  • International patent families
  • International patent priority and PCT
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Drug Master Files
  • Dynamic search capabilities with data
  • More…
See the Database
and Plan
. Contact Us with any

The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details

Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or